Join
Live feed
·
INSIDERFilingvia Quantisnow
Karyopharm Therapeutics Inc. logo

Director Schor Chen was granted 15,508 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
KPTI· Karyopharm Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KPTI (Karyopharm Therapeutics Inc.) and more on Quantisnow.

Director Schor Chen was granted 15,508 shares (SEC Form 4) | Quantisnow